[1] 中华医学会血液学分会血栓与止血学组.成人原发免疫性血小板减少症诊断与治疗中国指南(2020年版)[J].中华血液学杂志,2020,41(8):617-623.
[2] SUN D,SHEHATA N,Ye X Y,et al.Corticosteroids compared with intravenous immunoglobulin for the treatment of immune thrombocytopenia in pregnancy[J].Blood,2016,128(10):1329-1335.
[3] XU X,LIANG M Y,DOU S,et al.Evaluation of glucocorticoid compared with immunoglobulin therapy of severe immune thrombocytopenia during pregnancy:response rate and complication[J].Am J Reprod Immunol,2018,80(4):e13000.
[4] 李国芸,杨颖,赵孟军.应用大剂量静脉注射用免疫球蛋白治疗妊娠合并血小板减少症[J].中国输血杂志,2007,20(3):217-218.
[5] 冯兰兰,张建平.妊娠合并特发性血小板减少性紫癜110例临床分析[J].国际妇产科学杂志,2012,39(4):402-404.
[6] 巩海凤,王志洪.重组人血小板生成素治疗妊娠期血小板减少症的效果及对白介素、干扰素影响[J].中国计划生育学杂志,2019,27(12):1652-1655.
[7] KONG Z,QIN P,XIAO S,et al.A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy[J].Blood,2017,130(9):1097-1103.
[8] DI B C A,CURRAO M,PECCI A,et al.Revealing eltrombopag's promotion of human megakaryopoiesis through AKT/ERK-dependent pathway activation[J].Haematologica,2016,101(12):1479-1488.
[9] SUGITA M,KALOTA A,GEWRITZ A M,et al.Eltrombopag inhibition of acute myeloid leukemia cell survival does not depend on c-Mpl expression[J].Leukemia,2013,27(5):1207-1210.
[10] MICHEL M,RUGGERI M,GONZALEZ-LOPEZ T J,et al.Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy:results from a multicenter study[J].Blood,2020,136(26):3056-3061.
[11] SAMMARTANO V,SANTONI A,DEFINA M,et al.Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia[J].Blood Coagul Fibrinolysis,2020,31(6):416-418.
[12] FERREIRA I,SOUSA F,VASCO E M,et al.Severe immune thrombocytopenia in pregnancy treated with Eltrombopag-a case report[J].J Gynecol Obstet Hum Reprod,2018,47(8):405-408.
[13] WEINGARTEN S J,FRIEDMAN D,ARORA A.Eltrombopag use for refractory immune thrombocytopenia in pregnancy:a case report[J].Case Rep Womens Health,2021,29:e00281.
[14] 天际健康药品说明书:氨肽素片[EB/OL].[2021-05-04]. https://ypsm.yzsbh.com/drug?drugId=15766&q=%E6%B0%A8%E8%82%BD%E7%B4%A0&&show_navbar=true&show_header=true&show_navbar=true.
[15] 天际健康药品说明书:升白胺片[EB/OL].[2021-05-04].https://ypsm.yzsbh.com/drug?drugId=16419&q=%E7%9B%90%E9%85%B8%E5%B0%8F%E6%AA%97%E8%83%BA%E7%89%87&&show_navbar=true&show_header=true&show_navbar=true.
[16] 蔡玉萍.妊娠合并血小板减少症40例临床分析[J].齐齐哈尔医学院学报,2011,32(2):241-242.
[17] 杨九凌,祝晓玲,李成文,等.咖啡酸及其衍生物咖啡酸苯乙酯药理作用研究进展[J].中国药学杂志,2013,48(8):577-582.
[18] 张强,胡志力,王福文,等.咖啡酸对阿糖胞苷致小鼠白细胞、血小板减少及血小板体积变化的预防和治疗作用[J].中国临床药理学与治疗学,2008,13(5):508-511.
[19] 天际健康药品说明书:咖啡酸片[EB/OL].[2021-05-04].https://ypsm.yzsbh.com/drug?drugId=40747&q=%E5%92%96%E5%95%A1%E9%85%B8&&show_navbar=true&show_header=true&show_navbar=true.
[20] 秦平,魏昱,侯明,等.咖啡酸片治疗103例原发免疫性血小板减少症患者的多中心临床研究[J].中华血液学杂志,2015,36(2):103-106.
[21] 何迪,李斌,朱晓玲.咖啡酸片治疗免疫性血小板减少症的临床效果及安全性研究[J].临床血液学杂志,2020,33(5):344-347.
[22] LIU Y,QIU S,WANG L,et al.Reproductive and developmental toxicity study of caffeic acid in mice[J].Food Chem Toxicol,2019,123:106-112.
[23] 唐萍,陈义松.巴曲酶在血小板减少症孕妇围手术期的应用[J].医药导报,2003,22(10):698.
[24] 天际健康药品说明书:巴曲酶注射液[EB/OL].[2021-05-04].https://ypsm.yzsbh.com/drug?drugId=7915&q=%E5%B7%B4%E6%9B%B2%E9%85%B6&&show_navbar=true&show_header=true&show_navbar=true.
[25] 袁玉芳,杨晓春,何蓉,等.利妥昔单抗联合地塞米松治疗小儿难治性特发性血小板减少性紫癜临床效果观察[J].中国小儿血液与肿瘤杂志,2012,17(4):174-176.
[26] DESHAYES S,KHELLAF M,ZAROUR A,et al.Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia:results at 5 years from the French prospective registry ITP-ritux[J].Am J Hematol,2019,94(12):1314-1324.
[27] DONOHOE F,HIGGINS M,HIGGINS S,et al.Rituximab-a novel therapy for severe ITP in pregnancy:a case report[J].Obstet Med,2019,12(4):196-198.
[28] GALL B,YEE A,BERRY B,et al.Rituximab for management of refractory pregnancy-associated immune thrombocytopenic purpura[J].J Obstet Gynaecol Can,2010,32(12):1167-1171.
[29] RODEGHIERO F,MARRANCONI E.Management of immune thrombocytopenia in women:current standards and special considerations[J].Expert Rev Hematol,2020,13(2):175-185.
[30] 天际健康药品说明书:利妥昔单抗注射液[EB/OL].[2021-05-04].https://ypsm.yzsbh.com/drug?drugId=43716&q=%E7%BE%8E%E7%BD%97%E5%8D%8E&&show_navbar=true&show_header=true&show_navbar=true.
[31] 曹静,黄琨,徐敏.重组人白细胞介素-11联合糖皮质激素治疗免疫性血小板减少症的疗效分析[J].国际输血及血液学杂志,2016,39(1):4-8.
[32] 天际健康药品说明书:注射用重组人白介素-11[EB/OL].[2021-05-04].https://ypsm.yzsbh.com/drug?drugId=41259&q=%E6%B3%A8%E5%B0%84%E7%94%A8%E9%87%8D%E7%BB%84%E4%BA%BA%E7%99%BD%E4%BB%8B%E7%B4%A0-11&&show_navbar=true&show_header=true&show_navbar=true.
[33] 张小文,张逸帆,赵慧敏,等.重组人白细胞介素-11治疗免疫性血小板减少症患者的临床效果[J].临床医学研究与实践,2021,6(6):29-31.
[34] 邬扬炯,程韵枫,高松,等.重组人白细胞介素-11联合地塞米松治疗重症原发免疫性血小板减少症的疗效分析[J].中国临床医学,2012,19(6):588-590.
[35] UCHIDA T,AOYAMA K,MORI K,et al.Pharmacokinetics of[125I]-recombinant human interleukin-11:2.Placental transfer and excretion into milk after subcutaneous administration to rats[J].Eur J Drug Metab Pharmacokinet,1998,23(3):411-416. |
